Marker Therapeutics
MRKR
MRKR
28 hedge funds and large institutions have $8.52M invested in Marker Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
7
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$63.7K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$30.1K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$9.46K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.84K |
Top Sellers
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
-$103K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$16.7K |
| 3 |
Morgan Stanley
New York
|
-$13.6K |
| 4 |
BlackRock
New York
|
-$1.6K |
| 5 |
Renaissance Technologies
New York
|
-$1.29K |
